Literature DB >> 7750670

Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis.

T Ohkusa1, I Okayasu, S Tokoi, A Araki, Y Ozaki.   

Abstract

We previously reported that numerous macrophages which phagocytosed dextran sulfate sodium were observed to have accumulated in the mucosal lesions and in the spleen in experimental ulcerative colitis induced in mice with dextran sulfate sodium. In this paper, we investigated the bacterial phagocytic ability of macrophages which were isolated from spleens of mice treated with 3% dextran sulfate sodium for 6 months. In this model, the number of phagocytosed bacteria (Listeria monocytogenes) and the phagocytic index were significantly decreased. The phagocytic ability of splenic macrophages obtained from nontreated mice was also evaluated by incubating with dextran sulfate sodium in vitro, and adding bacteria. The number of phagocytosed bacteria and the phagocytic index were also significantly decreased. These observations suggest that the decrease in bacterial phagocytosis in this model by macrophages that phagocytosed dextran sulfate sodium indicates a decline of the mucosal defense system to bacteria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750670     DOI: 10.1159/000201236

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  18 in total

1.  Promotion of colorectal neoplasia in experimental murine ulcerative colitis.

Authors:  I Okayasu; T Ohkusa; K Kajiura; J Kanno; S Sakamoto
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

2.  Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in mice.

Authors:  Sou Ohkawara; Hideki Furuya; Kousuke Nagashima; Narito Asanuma; Tsuneo Hino
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

3.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

4.  The severity of dextran sodium sulfate-induced colitis can differ between dextran sodium sulfate preparations of the same molecular weight range.

Authors:  Shigeki Bamba; Akira Andoh; Hiromitsu Ban; Hirotsugu Imaeda; Tomoki Aomatsu; Ayako Kobori; Yosuke Mochizuki; Makoto Shioya; Takashi Nishimura; Osamu Inatomi; Masaya Sasaki; Yasuharu Saitoh; Tomoyuki Tsujikawa; Yoshio Araki; Yoshihide Fujiyama
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

5.  Effect of heparin on dextran sulfate sodium-induced colitis.

Authors:  J R Korzenik; A Hsu; M E Robert
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

6.  Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats.

Authors:  Antonella Vetuschi; Giovanni Latella; Roberta Sferra; Renzo Caprilli; Eugenio Gaudio
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

7.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

8.  Intestinal mucosal inflammation leads to systemic genotoxicity in mice.

Authors:  Aya M Westbrook; Bo Wei; Jonathan Braun; Robert H Schiestl
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

9.  Apoptosis inhibitor expressed by macrophages tempers autoimmune colitis and the risk of colitis-based carcinogenesis in TCRalpha-/- mice.

Authors:  Ikuko Haruta; Noriyuki Shibata; Yoichiro Kato; Masanori Tanaka; Makio Kobayashi; Hidetoshi Oguma; Keiko Shiratori
Journal:  J Clin Immunol       Date:  2007-07-06       Impact factor: 8.317

10.  The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice.

Authors:  Z Selmeczy; B Csóka; P Pacher; E S Vizi; G Haskó
Journal:  Inflamm Res       Date:  2007-05       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.